CpG1018
Showing 1 - 25 of 25
Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Alzheimer Dementia
- CpG1018
- Placebo
- (no location specified)
Jan 3, 2023
COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)
Active, not recruiting
- COVID-19
- SARS-CoV-2 protein subunit recombinant vaccine
- SARS-CoV-2 inactivated vaccine
-
Semarang, Central Java, Indonesia
- +1 more
Aug 8, 2022
Plague, Pneumonic, Plague, Vaccine-Preventable Diseases Trial in United States (rF1V vaccine and CpG 1018® adjuvant, rF1V
Recruiting
- Plague, Pneumonic
- +2 more
- rF1V vaccine and CpG 1018® adjuvant
- rF1V vaccine
-
Huntsville, Alabama
- +4 more
Aug 16, 2022
COVID-19 Trial in Kyiv, Vinnitsa (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline)
Terminated
- COVID-19
- CpG 1018/Alum-adjuvanted SCB-2019 vaccine
- +2 more
-
Kyiv, Ukraine
- +3 more
May 19, 2022
COVID-19 Trial in Taiyuan, Chengdu (Candidate Vaccine, SCB-2019, Placebo)
Active, not recruiting
- COVID-19
- Candidate Vaccine, SCB-2019
- Placebo
-
Taiyuan, Shanxi, China
- +1 more
Feb 22, 2022
COVID-19 Trial in Nedlands (SCB-2019, SCB-2019 with AS03 adjuvant, SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant)
Completed
- COVID-19
- SCB-2019
- +3 more
-
Nedlands, Western Australia, AustraliaLinear Clinical Research Ltd
Feb 17, 2022
COVID-19 Trial in Semarang, Makassar, Padang (SARS-CoV-2 protein subunit recombinant vaccine, )
Active, not recruiting
- COVID-19
- SARS-CoV-2 protein subunit recombinant vaccine
- placebo
-
Semarang, Central Java, Indonesia
- +2 more
Aug 8, 2022
COVID-19 Trial in Indonesia (COVID-19 Protein Subunit Recombinant Vaccine, Active Comparator)
Recruiting
- COVID-19
- COVID-19 Protein Subunit Recombinant Vaccine
- Active Comparator
-
Semarang, Central Java, Indonesia
- +3 more
Jun 26, 2022
COVID-19 Trial in Worldwide (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Placebo; 0.9% saline, SCB-2019 vaccine)
Recruiting
- COVID-19
- CpG 1018/Alum-adjuvanted SCB-2019 vaccine
- +3 more
-
Alken, Belgium
- +30 more
Feb 7, 2022
Shingles, Herpes Zoster, Vaccine-Preventable Diseases Trial in Australia (Z-1018, Shingrix)
Recruiting
- Shingles
- +2 more
- Z-1018
- Shingrix
-
Blacktown, New South Wales, Australia
- +3 more
Feb 8, 2022
SARS-CoV 2 Trial in Montréal, Québec (Intramuscular Vaccine)
Completed
- SARS-CoV 2
- Intramuscular Vaccine
-
Montréal, Quebec, Canada
- +1 more
Apr 4, 2022
Covid-19, SARS Pneumonia, Pneumonia, Viral Trial in Bangkok (Normal Saline, NDV-HXP-S vaccine)
Recruiting
- Covid-19
- +3 more
- Normal Saline
- NDV-HXP-S vaccine
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Mar 13, 2022
SARS-CoV-2 Virus Infection Trial in United Kingdom (VLA2001, AZD1222, VLA2001 - adolescent part)
Active, not recruiting
- SARS-CoV-2 Virus Infection
- VLA2001
- +3 more
-
Barnsley, United Kingdom
- +30 more
Oct 17, 2022
COVID-19 Trial (candidate vaccine, SCB-2020S)
Withdrawn
- COVID-19
- candidate vaccine, SCB-2020S
- (no location specified)
Sep 2, 2021
SARS-CoV-2 Infection Trial in Groningen, Utrecht, Auckland (VLA2001)
Active, not recruiting
- SARS-CoV-2 Infection
- VLA2001
-
Groningen, Netherlands
- +3 more
Jan 17, 2023
COVID-19 Trial in Cali (VLA 2001)
Not yet recruiting
- COVID-19
- VLA 2001
-
Cali, Valle, ColombiaCentro de Estudios en Infectología Pediátrica
Sep 15, 2022
COVID-19 Trial in Taipei (MVC-COV1901)
Completed
- COVID-19
- MVC-COV1901
-
Taipei, TaiwanNational Taiwan University Hospital
Jan 27, 2022
COVID-19 Disease, SARS Pneumonia, Pneumonia, Viral Trial in Hanoi, Thai Binh (COVIVAC, Phosphate-buffered saline)
Recruiting
- COVID-19 Disease
- +3 more
- COVIVAC
- Phosphate-buffered saline
-
Hanoi, Vietnam
- +1 more
Apr 1, 2021
Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])
Withdrawn
- Hepatitis B
- Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
-
Baltimore, Maryland
- +1 more
Jul 19, 2022
SARS-CoV-2 Virus Infection Trial in New Zealand (VLA2001)
Active, not recruiting
- SARS-CoV-2 Virus Infection
- VLA2001
-
Auckland, Birkenhead, New Zealand
- +7 more
Feb 3, 2022
Covid19 Trial in Porto Alegre, Rio De Janeiro, Natal (ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca), CoronaVac (Sinovac
Not yet recruiting
- Covid19
- ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca)
- +2 more
-
Porto Alegre, Rio De Grande Do Sul, Brazil
- +2 more
Oct 19, 2021
End Stage Renal Disease on Dialysis (Diagnosis) Trial in United States (HEPLISAV-B®)
Unknown status
- End Stage Renal Disease on Dialysis (Diagnosis)
-
Bloomfield, Connecticut
- +19 more
Dec 14, 2020
Severe Aortic Valve Stenosis Trial in Egypt, Lebanon, Saudi Arabia (Aortic valve replacement)
Not yet recruiting
- Severe Aortic Valve Stenosis
- Aortic valve replacement
-
Aswan, Egypt
- +6 more
May 4, 2023
Tumors Trial in Pamplona, Madrid (Urelumab + Nivolumab)
Unknown status
- Neoplasms
- Urelumab + Nivolumab
-
Pamplona, Navarra, Spain
- +1 more
Jan 2, 2019
Aging Trial in San Mateo (Plasma Transfusion)
Unknown status
- Aging
- Plasma Transfusion
-
San Mateo, CaliforniaThe Infusion Center & Clinic
Jan 14, 2018